Search

Your search keyword '"A, Da Porto"' showing total 16 results
Start Over Author "A, Da Porto" Journal nephron
16 results on '"A, Da Porto"'

1. Contents, Vol. 65, 1993

Author

S. Delons, Dubravka Čvoriščec, Natale G. DeSanto, C. Senent, G. Calconi, Emil C. Reisinger, Heinz F. Hammer, Zensuke Ota, Eisuke Takazakura, C. Pascual, A. Vianello, Soo Wan Kim, Giovambattista Capasso, Yukihiro Fujimoto, M. Chaussidon, Y. Bar-Khayim, Akio Yoshida, Charles W. Tomlinson, P. Fener, F. Cerri, Valerie R. Walker, Naoki Kashihara, Günter F. Enzinger, Maria-Eugenia Carazo, Jongeun Lee, B.L. Rayner, Massimo Cirillo, Ankica Vuković-Holjevac, Arzu Sungur, Hiromoto Kosaka, C. Caldato, Jean-Pierre Girolami, F. Mariotti, S. Mastrosimone, Senji Sakanaka, Ünal Yasavul, Wayne Taylor, C. Martorano, A. Magnasco, P. Escalada, A. Kagan, Guy Bompart, C. Zoccali, Akira Takeda, Kee-Lam Wong, Hiroto Mashiba, Martin Muntzel, Luis Borque, Anthony E.G. Raine, Hirofumi Makino, F. Ciardella, G. Palminteri, Hikokichi Oura, David B.G. Oliveira, Christiane Pecher, G. Garibotto, D. Delfino, Michał Nowicki, S. Sánchez-Fructuoso, M. Marchelli, Ryoichi Sato, M. Santoni, H. Membre, C. Catalano, Cem Sungur, Masayuki Iwano, Yasuhito Saito, Allain Collé, Linda L. Longerich, Ignatius K.P. Cheng, Mujo Kim, Takaki Mizusawa, Nyat Kooi Chin, Sali Caglar, Yasushi Tanaka, Günter J. Krejs, R. Diaz-Tejeiro, Takatoshi Michigishi, C. Perez-Carral, Masao Hattori, Shin-ichi Takeda, G. Enia, A. da Porto, Edward S. Hyman, Elisabeth R. Mathiesen, Yoshio Nagake, Wei-Perng Chen, Joanne Gorman, G. Fernandez, Eli G. Vey, Chiaki Shigemasa, Akihiko Hatano, Antonio Gil-Paraiso, Eric F.C. Wong, Saime Paydas, David N. Churchill, G.P. Bernini, Takako Yokozawa, Jorge del Cura, M.J.D. Cassidy, Wai Choong Lye, L. Sinay-Trieman, F. Franchi, Kazue Hironaka, M.C. Maresca, David B. Evans, Krešo Lipovac, Kenji Obara, Herwig Holzer, Toshiki Tsutsui, Cetin Turgan, Yoke-Sun Lee, Peter Raggatt, Eric Stanton, N.S. Levitt, Nam Ho Kim, Jin-Yao Lin, Yasushi Katayama, Kazuhiro Dohi, Narimasa Hirata, Tak Mao Chan, Ki Chul Choi, Albert Adam, Jörg H. Horina, Masahiro Kuroda, Murat Sert, Carlos Maside, A. Sofia, J.E. García, Isao Ishikawa, M. Kessler, Tekin Akpolat, C. Robaudo, Elizabeth M. Evans, Bernard Lacour, Ana Stavljenić, Tamer Tetiker, M.R. Sala, Eric Goffin, Andrzej Wiecek, Mary Louise Beecroft, Masayuki Takeda, M. de la Torre, Ching-Yuang Lin, P. Netter, Ichiro Hisatome, Dubravka Juretić, G. Gurreri, Tilman B. Drüeke, B. Czernobilsky, Roger A.L. Sutton, Kwang Ki Park, Graham Lipkin, Franciszek Kokot, N. Barzilai, R. Peces, E. Gomez, Norman L.M. Wong, Ali Ergen, F. Albarède, Kyoung Hyup Moon, Hiroshi Kotake, Jasminka Benković, Kwok Wah Chan, A. D’Annibale, G. Brogi, Thierry Hannedouche, S. Saffioti, T. Sierra, Shotaro Sato, Iain C. Macdougall, E. Özyilkan, Hitoshi Takahashi, Henry Gault, Angel Sánchez-Casajús, Takeshi Komeyama, and Marina Lemos Dos Reiss

Subjects
Traditional medicine, business.industry, Medicine, business
Published
1993
Full Text
View/download PDF

2. Subject Index, Vol. 65, 1993

Author

Massimo Cirillo, A. Kagan, Senji Sakanaka, David B. Evans, A. D’Annibale, A. Magnasco, G. Enia, Takako Yokozawa, Takatoshi Michigishi, Guy Bompart, Jin-Yao Lin, C. Catalano, Cem Sungur, Jean-Pierre Girolami, Hiroto Mashiba, Jörg H. Horina, Shotaro Sato, M.C. Maresca, Wei-Perng Chen, G. Brogi, Yasushi Tanaka, Günter J. Krejs, C. Perez-Carral, M.J.D. Cassidy, Zensuke Ota, C. Pascual, Sali Caglar, Cetin Turgan, S. Saffioti, H. Membre, Antonio Gil-Paraiso, G. Fernandez, S. Delons, Giovambattista Capasso, Dubravka Čvoriščec, Yoshio Nagake, Eric F.C. Wong, Michał Nowicki, G.P. Bernini, Naoki Kashihara, T. Sierra, Nyat Kooi Chin, V. R. Walker, Wai Choong Lye, P. Netter, Hitoshi Takahashi, Eisuke Takazakura, P. Fener, F. Cerri, Kazue Hironaka, R. Diaz-Tejeiro, F. Mariotti, S. Mastrosimone, Herwig Holzer, Heinz F. Hammer, Edward S. Hyman, Albert Adam, Bernard Lacour, Ching-Yuang Lin, Martin Muntzel, Hiroshi Kotake, Jasminka Benković, Günter F. Enzinger, Takaki Mizusawa, Dubravka Juretić, Maria-Eugenia Carazo, Ana Stavljenić, Kwok Wah Chan, Yoke-Sun Lee, Ichiro Hisatome, Anthony E.G. Raine, Iain C. Macdougall, David B.G. Oliveira, M. de la Torre, B.L. Rayner, A. Vianello, D. Delfino, Nam Ho Kim, Hirofumi Makino, Tilman B. Drüeke, G. Gurreri, E. Özyilkan, Henry Gault, G. Garibotto, C. Senent, G. Calconi, Arzu Sungur, Emil C. Reisinger, David N. Churchill, Christiane Pecher, Masayuki Iwano, C. Zoccali, Thierry Hannedouche, Ankica Vuković-Holjevac, Akira Takeda, F. Franchi, Kee-Lam Wong, Allain Collé, Hikokichi Oura, Saime Paydas, G. Palminteri, L. Sinay-Trieman, M. Marchelli, Yasuhito Saito, Shin-ichi Takeda, Joanne Gorman, Soo Wan Kim, M. Chaussidon, Y. Bar-Khayim, Eric Stanton, S. Sánchez-Fructuoso, A. da Porto, Isao Ishikawa, Jorge del Cura, Hiromoto Kosaka, N.S. Levitt, Mujo Kim, Elizabeth M. Evans, Masahiro Kuroda, Wayne Taylor, Tamer Tetiker, Krešo Lipovac, Toshiki Tsutsui, C. Martorano, Akio Yoshida, C. Caldato, M. Santoni, Charles W. Tomlinson, Franciszek Kokot, F. Ciardella, Natale G. DeSanto, Ignatius K.P. Cheng, C. Robaudo, Norman L.M. Wong, Carlos Maside, Andrzej Wiecek, Yukihiro Fujimoto, Masayuki Takeda, Ki Chul Choi, Ali Ergen, Murat Sert, B. Czernobilsky, Kazuhiro Dohi, Tak Mao Chan, Graham Lipkin, N. Barzilai, R. Peces, Eli G. Vey, Chiaki Shigemasa, F. Albarède, Kyoung Hyup Moon, Roger A.L. Sutton, Kwang Ki Park, E. Gomez, A. Sofia, M. Kessler, Tekin Akpolat, Eric Goffin, Mary Louise Beecroft, Jongeun Lee, Masao Hattori, Elisabeth R. Mathiesen, Marina Lemos Dos Reiss, Peter Raggatt, Narimasa Hirata, Kenji Obara, J.E. García, M.R. Sala, Takeshi Komeyama, Ünal Yasavul, P. Escalada, Luis Borque, Ryoichi Sato, Linda L. Longerich, Yasushi Katayama, Akihiko Hatano, and Angel Sánchez-Casajús

Subjects
Index (economics), business.industry, Statistics, Medicine, Subject (documents), business
Published
1993
Full Text
View/download PDF

3. Intraperitoneal infusion of dialysate: a possible cause of increased plasma atrial natriuretic peptide levels

Author

Galardi N, V. Salandin, P. Calzavara, C Bocci, G Da Rin, A. Vianello, A. da Porto, and Gianpaolo Amici

Subjects
Male, medicine.medical_specialty, business.industry, Endocrinology, Text mining, Atrial natriuretic peptide, Peritoneal Dialysis, Continuous Ambulatory, Internal medicine, Dialysis Solutions, medicine, Humans, Female, Infusions, Parenteral, business, Atrial Natriuretic Factor, Aged, Uremia
Published
1993

4. Influence of donor age on cadaver kidney graft function and survival: univariate and multivariate analyses

Author

G. Calconi, M. C. Maresca, S. Mastrosimone, G. Palminteri, A. Vianello, A. da Porto, C. Caldato, and Annibale D’Annibale

Subjects
Adult, Male, medicine.medical_specialty, Aging, Multivariate analysis, Adolescent, Urology, Renal function, Diuresis, Kidney, Cyclosporin a, Cadaver, Medicine, Humans, Child, Kidney transplantation, Aged, Immunosuppression Therapy, Proteinuria, business.industry, Graft Survival, Age Factors, Middle Aged, medicine.disease, Kidney Transplantation, Tissue Donors, Surgery, Transplantation, medicine.anatomical_structure, Multivariate Analysis, Cyclosporine, Female, medicine.symptom, business
Abstract

The influence of donor age on the outcome of kidney transplantation (TX) was evaluated in 169 patients who received a primary cadaver kidney transplant at our center between September 16,1984, and December 31,1990. All the patients received cyclosporin A as part of the immunosuppressive protocol. Patients were grouped according to donor age: low donor age (LDA; donor age range 12-25 years), medium donor age (MDA; range 26-50 years) and high donor age (HDA; range 51-66 years). There were no differences between groups in graft and patient survival, and multivariate analysis did not show any effect of donor age on those parameters. Proteinuria/day and number of rejection episodes did not differ between groups either. Immediate diuresis was more frequent in group LDA than in the other two groups (73.8, 54.7 and 57.1%, respectively; p Cr) at every period after TX but the 5th year, with r2 from 0.12 to 0.23 (p Crthan the HDA group at every period after TX but for the 5th year (the MDA group behaved intermediately). Moreover, in the 65 patients with a follow-up of 4 years or more, not only did the LDA group have the best CCr (LDA vs. MDA and HDA: p Cr remained roughly stable with time in groups LDA and MDA while it declined progressively with time in group HDA. The influence of donor age on hypertension after TX was negligible when compared to that of dialytic age and recipient sex. Our data show that kidneys from donors 12-25 years old give the best functional results, while those from donors over 50 are associated with the lowest kidney function. Moreover, if the reduced frequency of immediate diuresis and the progressive decline of CCr with time are taken into account, kidneys from donors over 50 are also probably associated with reduced graft survival in the long term (after the 10th year). We suggest that kidneys from donors over 50 may be used, but they should be probably given to patients with a life expectation of no more than 10-15 years.

Published
1993

5. Long-term survival on renal replacement therapy for primary hyperoxaluria type I

Author

Ermanno Bonucci, M. C. Maresca, G. Calconi, Paola Ballanti, Da Porto A, A. Vianello, Petrarulo M, P. Calzavara, and Marangella M

Subjects
Adult, Male, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Nephropathy, Renal Dialysis, medicine, Primary Hyperoxaluria Type I, Humans, Renal replacement therapy, Kidney transplantation, Dialysis, Transaminases, Hyperparathyroidism, Oxalates, Alanine, business.industry, medicine.disease, Kidney Transplantation, Surgery, Glycolates, Transplantation, Liver, Hyperoxaluria, Primary, Kidney Failure, Chronic, Hemodialysis, business
Abstract

We describe the case of a patient in end-stage renal failure due to primary hyperoxaluria type I (PH1) who started hemodialysis in 1977 and is still alive and active. The diagnosis of PH1 was first suspected after a bone biopsy performed in 1981 to investigate hyperparathyroidism. Oxalosis recurred as early as 3 months after transplantation in a cadaver kidney grafted in 1987; nevertheless, graft function remained good enough to make possible the discontinuation of dialysis treatment for 5 months and thereafter to have only 1 dialysis a week for 17 months. The diagnosis of PH1 has been recently confirmed despite the patient being already anuric by means of the determination of plasma oxalate and glycolate levels as well as by determining hepatic alanine:glyoxylate amino-transferase.

Published
1993

6. Hepatitis C virus in dialysis units: a multicenter study

Author

Gianpaolo Amici, F Susanna, M.R. Castelletto, P. Calzavara, P. Poli, A. da Porto, L. Okolicsanyi, T. Teodori, and A. Adami

Subjects
medicine.medical_specialty, Hepacivirus, medicine.medical_treatment, Hepatitis C virus, medicine.disease_cause, Gastroenterology, Renal Dialysis, Internal medicine, Epidemiology, medicine, Humans, Hepatitis Antibodies, Dialysis, Cross Infection, biology, business.industry, Incidence (epidemiology), Transfusion Reaction, Alanine Transaminase, Hepatitis C, medicine.disease, biology.organism_classification, Surgery, Hemodialysis Units, Hospital, Alanine transaminase, Italy, biology.protein, Hemodialysis, business
Abstract

Three hundred and eighty-seven chronic hemodialysis patients were evaluated, in a multicenter study, to investigate the epidemiology of hepatitis C virus. In anti-HCV seropositive patients, serum ALT values and blood transfusions were retrospectively compared; blood donors were studied for serum transaminases. In seropositive patients without previous blood transfusions, analysis of dialysis schedule was done. Eventually, the intrafamilial transmission of hepatitis C virus was studied in 104 family members. The prevalence of HCV infection in hemodialysis patients was 15.7%. The incidence of acute hepatitis was frequent, while chronic hepatitis incidence was less than expected (17.5%). Intrafamilial diffusion was low (1.9%). Blood-transfusion-related infections seem to be negligible, while cross-contamination in dialysis units seems to be very important.

Published
1992

7. Hypercalcemia and Insomnia in Hemodialysis Patients

Author

L Stanic, Virga G, F. Gastaldon, A. da Porto, S. Mastrosimone, and A. Bonadonna

Subjects
medicine.medical_specialty, business.industry, medicine.medical_treatment, MEDLINE, Renal Dialysis, Dialysis Solutions, Sleep Initiation and Maintenance Disorders, Hypercalcemia, Insomnia, medicine, Humans, Kidney Failure, Chronic, Calcium, Hemodialysis, medicine.symptom, Intensive care medicine, business
Published
2000
Full Text
View/download PDF

10. Comparison between First- and Second-Generation Test for Anti-Hepatitis C Virus Antibodies in Hemodialysis Patients

Author

C. Cascone, P. Calzavara, T. Teodori, L. Okolicsanyi, A. Adami, P. Poli, A. da Porto, Gianpaolo Amici, and M.R. Castelletto

Subjects
biology, business.industry, Anti-Hepatitis C Virus Antibodies, Hepatitis C virus, medicine.medical_treatment, Immunoblotting, Process improvement, Enzyme-Linked Immunosorbent Assay, Hepacivirus, Elisa assay, medicine.disease_cause, Hepatitis C, Virology, Virus, Renal Dialysis, Dialysis unit, medicine, biology.protein, Humans, Hepatitis Antibodies, Hemodialysis, Diagnostic Errors, Antibody, business
Abstract

The serum of 387 hemodialysis patients from 9 dialysis units was checked for anti-hepatitis C virus antibodies with a 1st-generation ELISA (Ortho) test: 61 patients were repeatedly positive. In order to avoid false-positive results, these sera were tested with a 1st-generation confirmatory RIBA test, 2nd-generation screening ELISA test and 2nd-generation confirmatory RIBA test. The 2nd-generation ELISA test confirmed data obtained with 1st-generation ELISA, however, the 1st-generation confirmatory RIBA test underestimated the number of anti-HCV-positive patients.

Published
1992
Full Text
View/download PDF

16. Long-term survival on renal replacement therapy for primary hyperoxaluria type I.

Author

Calzavara P, Marangella M, Petrarulo M, Ballanti P, Bonucci E, Calconi G, Maresca MC, da Porto A, and Vianello A

Subjects
Adult, Alanine analysis, Glycolates blood, Humans, Hyperoxaluria, Primary blood, Hyperoxaluria, Primary complications, Kidney Failure, Chronic blood, Kidney Failure, Chronic surgery, Liver enzymology, Male, Oxalates blood, Renal Dialysis, Time Factors, Transaminases analysis, Hyperoxaluria, Primary surgery, Kidney Transplantation
Abstract

We describe the case of a patient in end-stage renal failure due to primary hyperoxaluria type I (PH1) who started hemodialysis in 1977 and is still alive and active. The diagnosis of PH1 was first suspected after a bone biopsy performed in 1981 to investigate hyperparathyroidism. Oxalosis recurred as early as 3 months after transplantation in a cadaver kidney grafted in 1987; nevertheless, graft function remained good enough to make possible the discontinuation of dialysis treatment for 5 months and thereafter to have only 1 dialysis a week for 17 months. The diagnosis of PH1 has been recently confirmed despite the patient being already anuric by means of the determination of plasma oxalate and glycolate levels as well as by determining hepatic alanine:glyoxylate amino-transferase.

Published
1993
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results